However, decreased granzyme B (+) CD19 (+) B cells were correlated with early recurrence in HCC patients after liver transplantation with poor tumor differentiation, microvascular invasion, increased total tumor diameter, and tumor beyond Milan criteria26. Here, CD19 is linked to hepatocellular carcinoma.